Thomas H. Lee Partners, L.P. (THL) announced that it acquired the remaining share of Agiliti, Inc. for $10.00 per share, implying a total enterprise value of $2.5 billion.
Agiliti is an essential service provider to the U.S. healthcare industry with solutions that help support a more efficient, safe and sustainable healthcare delivery system. Agiliti serves more than 10,000 national, regional and local acute care and alternate site providers across the country. According to the company’s financial statements, it reported $1.2 billion in revenue for the full year 2023.
THL is one of the world’s oldest and most experienced private equity firms. Since 1974, it has raised more than $34 billion of equity capital, invested in more than 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value of more than $210 billion.
As a result of the closing of the transaction, trading of Agiliti common stock has been suspended on the New York Stock Exchange and Agiliti has requested that its common stock be delisted from the NYSE.
Centerview Partners LLC acted as exclusive financial advisor to the Special Committee of the Board of Directors of Agiliti. Weil, Gotshal & Manges LLP acted as legal counsel to the Special Committee. Goldman Sachs & Co. LLC acted as exclusive financial advisor to THL. Ropes & Gray LLP acted as legal counsel to THL.
According to data captured in the LevinPro HC database, this acquisition represents the 33rd Medical Devices transaction of 2024. This is also THL’s first acquisition of the year.
